Global Digital Polymerase Chain Reaction Market Size, Share, Growth Analysis Report - Forecast 2034

Digital Polymerase Chain Reaction Market: Industry Perspective

The global digital polymerase chain reaction market size was worth around USD 7.16 Billion in 2024 and is predicted to grow to around USD 17.66 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 9.45% between 2025 and 2034.

The report analyzes the global digital polymerase chain reaction market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital polymerase chain reaction industry.

Request Free Sample

Digital Polymerase Chain Reaction Market: Overview

Digital PCR is a laboratory technique used to produce a number of copies of specific pieces of DNA from samples consisting of small amounts of DNA. PCR permits pieces of DNA to be amplified for the detection process. Additionally, it is a highly sensitive quantification of nucleic acid, which is very precise. Furthermore, it is used for the absolute analysis of minority sequences and quantification. This PCR method does not rely on the quantification of sample targets. This type of PCR can detect rare events like single-nucleotide mutation, particularly of wild-type sequences in the samples. It is considered a crucial tool in patient monitoring, personalized treatment, diagnosis, cancer studies, and follow-up management.

Key Insights

• As per the analysis shared by our research analyst, the global digital polymerase chain reaction market is estimated to grow annually at a CAGR of around 9.45% over the forecast period (2025-2034).
• Regarding revenue, the global digital polymerase chain reaction market size was valued at around USD 7.16 Billion in 2024 and is projected to reach USD 17.66 Billion by 2034.
• The digital polymerase chain reaction market is projected to grow at a significant rate due to increasing demand for precise genetic analysis, advancements in molecular diagnostics, and growing applications in cancer, infectious diseases, and genetic research.
• Based on Product Type, the Digital PCR Instruments segment is expected to lead the global market.
• On the basis of Technology, the Droplet Digital PCR segment is growing at a high rate and will continue to dominate the global market.
• Based on the Application, the Clinical Diagnostics segment is projected to swipe the largest market share.
• By End User, the Academic & Research Organizations segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Digital Polymerase Chain Reaction Market: Growth Drivers

Transformation to chip-based digital PCR from traditional droplets-based tests will boost growth of global market.

There is a significant shift from droplet to chip-based dPCR diagnosis of a wide range of diseases. Such advancements in the field of digital PCR devices are likely to drive the growth of the global digital polymerase chain reaction market exponentially in the forthcoming years. Furthermore, in the commercially operating droplet dPCR, the droplets need to be transferred manually, which leads to the target underestimation. Also, such kits pose a risk of cross-contamination while detecting the samples. On the other hand, the droplets run through channels in the chipset digital polymerase chain reaction that involves a lower risk of cross-contamination, thereby propelling its demand. Innovation is likely to fuel the adoption of chip-based digital PCR for the diagnosis of a wide range of diseases in the coming years.

Digital Polymerase Chain Reaction Market: Restraints

Expensive digital PCR devices are likely to hamper the growth of the global market.

There is a global spike in the incidences of infectious diseases, genetic disorders, and cancer among populations. But still, there is a low adoption rate of digital polymer chain reaction techniques due to the high cost of available digital PCR devices in the market.

Digital Polymerase Chain Reaction Market: Opportunities

Growing applications of digital PCR in veterinary and microbiological sciences are likely to open several new avenues in the global market.

The global digital polymerase chain reaction market is expected to witness a significant opportunistic focus due to the large-scale utilization of novel applications in laboratories. There is growing adoption of these techniques, particularly in veterinary and microbiology sciences, which in turn is likely to create huge opportunities in the forthcoming years. Furthermore, the automation of advanced instruments has powered healthcare professionals and scientists to detect genetic samples with quantitative accuracy at a lower cost. Apart from this, lesser hands-on involvement during the sample detection is likely to increase the quality of output, reduce foreign contamination, and save time.

Request Free Sample

Digital Polymerase Chain Reaction Market: Challenges

Lack of awareness among people is a huge challenge in the global market.

Despite the growing incidences of chronic illness among people globally, there is comparatively lesser demand for digital PCR due to the lack of awareness among people, which in turn is likely to emerge as a huge challenge in the global marketplace.

Digital Polymerase Chain Reaction Market: Segmentation

The global digital polymerase chain reaction market can be segmented into end-user, application, product type, technology, and region.

By technology, the market can be segmented into BEAMing digital PCR, chip-based digital PCR, and droplet digital PCR.

By product type, the market can be segmented into software & services, consumables & reagents, and digital PCR systems. The software & services segment accounts for the largest share in the global market due to the fact that it helps in enhancing the efficiency of management of digital PCR, thereby propelling the demand in the market.

By application, the market can be segmented into forensic, clinical, diagnostic, research, and others.

By end-user, the market can be segmented into universities, clinical diagnostic laboratories, pharmaceutical & biotechnology industry, and others.

Digital Polymerase Chain Reaction Market: Report Scope

Recent Developments

• QIAGEN, in January 2021, announced the launch of a dPCR platform "Qiacity" for wastewater and mutation testing. It will help enhance its product portfolio of COVID-19 testing solutions.
• BioMerieux SA in 2020 got the approval for Sars COV-2 gene tests that include saliva specimens.

Digital Polymerase Chain Reaction Market: Regional Landscape

North America accounts for the largest share in the global digital polymerase chain reaction market due to the presence of well-established healthcare infrastructure in the region. Furthermore, the presence of leading molecular diagnostic and associated manufacturers in the region will further propel the growth of the regional market.

Asia Pacific is likely to grow with a high CAGR in the global market during the forecast period due to the growing number of patients suffering from chronic and infectious diseases.

Digital Polymerase Chain Reaction Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the digital polymerase chain reaction market on a global and regional basis.

The global digital polymerase chain reaction market is dominated by players like:

• Bio-Rad Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Qiagen
• Danaher Corporation
• Eurofins Scientific
• JN Medsys
• Merck KGaA
• F. Hoffmann-La Roche Ltd.
• Stilla Technologies
• Standard BioTools
• Sysmex Inostics Inc.

The global digital polymerase chain reaction market is segmented as follows;

By Product Type

• Digital PCR Instruments
• Consumables & Reagents
• Software & Services

By Technology

• Droplet Digital PCR
• Chip-Based Digital PCR
• Others

By Application

• Clinical Diagnostics
• Research
• Forensics
• Others

By End User

• Academic & Research Organizations
• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America